Single Dose Of Psilocybin Causes Long-Term Remission Of Depression In Over 50% Of Cancer Patients | Psychedelic spotlight

Great news for those researching new treatments for depression in cancer patients! Positive long-term follow-up data has just been released from Sunstone Therapies investigator-initiated Phase 2 study evaluating synthetic psilocybin COMPASS Pathways, with some rather promising results.

Administration of a single 25 mg dose of psilocybin combined with psychological support resulted in 57% of patients sustaining remission of depression, with 64% experiencing a robust clinical response 18 months later.